Delivery Order SPE2DB24D3015-SPE2DB25FFXPT

Award Date 1/7/25
Potential Completion Date 1/8/25
Potential Value $6.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $6,162.59 firm fixed-price contract is for the delivery of APLENZIN ER 522 MG TABLET 30S, a prescription medication. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is valued at $14,042.49 and has an ultimate completion date of December 11, 2024. The contract is for the delivery of APLENZIN ER 522 MG TABLET 30S, a pharmaceutical product. This contract is a part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at...
This is a $7,370.87 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of APLENZIN ER 348 MG TABLET 30S, a prescription medication. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of...
This is a $9,440.31 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide APLENZIN ER 348 MG TABLET 30S. The contract has an ultimate completion date of May 8, 2023. This order is part of a larger $999,999,999 Indefinite Delivery Contract that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of pharmaceutical products, including the medication APLENZIN ER 348 MG TABLET 30S. The contract has a ceiling value of $14,562.42 and is a Firm Fixed Price arrangement. AmerisourceBergen, a major pharmaceutical distributor, will provide these medical commodities to support military treatment facilities and healthcare programs. The contract has no set-aside designation...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of APLENZIN ER 174 MG TABLET 30S, a pharmaceutical product, with a ceiling value of $26,982.26. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of February 18, 2025. AmerisourceBergen holds a significant Indefinite Delivery...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $34,315.44 firm fixed-price contract is for the supply of APLENZIN ER 522 MG TABLET 30S, a prescription medication, with a performance period ending on May 17, 2023. The contract is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite...
This federal contract award, valued at $13,186.34, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of APLENZIN ER 522 MG TABLET 30S, a prescription medication. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This...
The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at approximately $8,295 to Amerisourcebergen Drug Corporation for the supply of 348 mg APLENZIN ER tablets. The prime contractor will deliver 30 tablets to a facility located in Conshohocken, Pennsylvania by July 31, 2023 in fulfillment of this order issued under an existing indefinite-delivery/indefinite-quantity contract vehicle. No subcontractors or set aside designations were identified. The...
This is a $1,119.16 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ADZENYS XR-ODT 6.3 MG TABLET UD 30S, a prescription medication, with a completion date of February 25, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
  • SPE2DB24D3015
    Indefinite Delivery Contract
  • SPE2DB24D3015-SPE2DB25FFXPT
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,815.42, is for the delivery of APLENZIN ER 348 MG TABLET 30S, a pharmaceutical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 5/21/25, 10:15 AM